Abstract: The present invention relates to: a substituted thiazolidinedione derivative compound having a novel structure acting as a sterol regulatory element-binding protein-1 (SREBP1) inhibitor, a hydrate thereof, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating cancer, comprising same as an active ingredient.

Abstract: Provided is a method of manufacturing an ethylene-acrylic acid copolymer including the step of (S1) supplying an ethylene monomer and an acrylic acid comonomer to a polymerization reactor to manufacture an ethylene-acrylic acid copolymer; (S2) supplying an acrylic acid comonomer-containing mixture discharged from a front or rear end of the polymerization reactor and a cleaning solvent to a cleaning unit; and (S3) dissolving an polyacrylic acid derived from the acrylic acid comonomer contained in the mixture in the cleaning solvent. The cleaning solvent includes a polyhydric alcohol-based solvent.

Abstract: A secondary battery comprising a positive electrode current collector, a first positive electrode mixture layer disposed on the positive electrode current collector and including a first positive electrode active material and a binder, and a second positive electrode mixture layer disposed on the first positive electrode mixture layer and including a second positive electrode active material and a binder. A nickel content of the second positive electrode active material is 80% by weight or less of a nickel content of the first positive electrode active material. By providing a secondary battery including a positive electrode of a multi-layer structure that includes positive electrode active materials having different contents of nickel, a secondary battery capable of improving high-temperature characteristics while maintaining energy density may be provided.

Abstract: Provided is a composition and a fructose production method, wherein the composition contains: sucrose phosphorylase or a microorganism expressing same; or a culture or lysate of the microorganism whereby fructose can be produced at low cost with high yield.

Abstract: The present invention provides a marker composition for selecting a living modified organism, which allows transformation and the production of a target product without antibiotics or antibiotic resistance genes, a living modified organism, a method of transforming an organism, and a method of producing a target product. The present invention provides a marker composition for selecting a living modified organism, which may basically prevent problems caused by the use of antibiotics and antibiotic resistance genes and produce a target product at a high yield, a living modified organism, a method of transforming an organism, and a method of producing a target product.

Abstract: A marker composition for selecting a living modified organism allows transformation and the production of a target product without antibiotics or antibiotic resistance genes. The marker composition for selecting a living modified organism may basically prevent problems caused by the use of antibiotics and antibiotic resistance genes and produce a target product at a high yield.

Abstract: A marker composition for selecting a living modified organism allows transformation and the production of a target product without antibiotics or antibiotic resistance genes. The marker composition for selecting a living modified organism may basically prevent problems caused by the use of antibiotics and antibiotic resistance genes and produce a target product at a high yield.